 A new multicenter clinical study reported in Science Translational Medicine has provided comprehensive answers and peeled away some of the mysteries surrounding poor outcomes for older people. Scientists from the University of California, San Francisco, and their far-flung collaborators throughout the United States examined the infection's progression by studying a large longitudinal clinical cohort.